Zobrazeno 1 - 8
of 8
pro vyhledávání: '"K. H. Tolley"'
Publikováno v:
Haemophilia. 5:378-385
The objectives of this study were to analyse current levels of health-related quality-of-life (HR-QoL) in individuals with severe haemophilia and to assess the scope for these levels to improve. To do this, 249 individuals with severe, moderate and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f078dc99cf9c04aea34876f631c9ce19
https://doi.org/10.1046/j.1365-2516.1999.00347.x
https://doi.org/10.1046/j.1365-2516.1999.00347.x
Publikováno v:
Psychology, Health & Medicine. 4:5-15
Severe haemophilia is a chronically disabling and painful condition but treatment may modify progression of the disease and consequently health-related quality-of-life (HR-QoL). In order to assess HR-QoL in patients with severe haemophilia A and B, 9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fd3286d518aa8735e4a8bb1280df716
https://doi.org/10.1080/135485099106360
https://doi.org/10.1080/135485099106360
Publikováno v:
Journal of Internal Medicine. 244:515-522
Miners AH, Sabin CA, Tolley KH, Lee CA (Royal Free Hospital School of Medicine, London; University Hospital Queen's Medical Centre, Nottingham; and Royal Free Hampstead NHS Trust, London, UK). Assessing the effectiveness and cost-effectiveness of pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96196f2394ea586ef113f5bf62f6b9cb
https://doi.org/10.1111/j.1365-2796.1998.00396.x
https://doi.org/10.1111/j.1365-2796.1998.00396.x
Publikováno v:
Haemophilia. 4:4-9
The annual amount of clotting factor used by patients at the Royal Free Haemophilia Centre increased significantly from 4 million iu in 1980 to over 15 million iu by 1994 (P < 0.0001). In order to assess the reasons for this increase, data on concent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67929e789c3457e3d9846562ab6c78da
https://doi.org/10.1046/j.1365-2516.1998.00129.x
https://doi.org/10.1046/j.1365-2516.1998.00129.x
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 7(5)
In this study, we assessed whether severity of haemophilia was associated with levels of productivity. Productivity levels were assessed by sending a 'time-use' questionnaire to 228 individuals with mild, moderate and severe haemophilia. The results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3f3427d0ce8652af5629f368926860ef
https://pubmed.ncbi.nlm.nih.gov/11554932
https://pubmed.ncbi.nlm.nih.gov/11554932
Publikováno v:
Journal of internal medicine. 247(4)
Miners AH, Sabin CA, Tolley KH, Lee CA (Royal Free Hospital School of Medicine, London; University of Nottingham, Nottingham; and Royal Free Hampstead NHS Trust, London, UK). Primary prophylaxis for individuals with severe haemophilia: how many hospi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d09d58401646098f3b7493ee9fd56d1
https://pubmed.ncbi.nlm.nih.gov/10792564
https://pubmed.ncbi.nlm.nih.gov/10792564
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 5(6)
The objectives of this study were to analyse current levels of health-related quality-of-life (HR-QoL) in individuals with severe haemophilia and to assess the scope for these levels to improve. To do this, 249 individuals with severe, moderate and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9d663dc05cabb46079f31ba95c48242b
https://pubmed.ncbi.nlm.nih.gov/10583523
https://pubmed.ncbi.nlm.nih.gov/10583523
Publikováno v:
Journal of internal medicine. 244(6)
To assess the effectiveness and cost-effectiveness of prophylaxis with clotting factor against bleeding in patients with severe haemophilia and von Willebrand's disease (vWD).Treatment details that related to 179 patients with severe (1 u dL-1) haemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b52586ea87d4c7982d03ccb3ebd95f7b
https://pubmed.ncbi.nlm.nih.gov/9893105
https://pubmed.ncbi.nlm.nih.gov/9893105